3.The therapeutic effects of insulin lispro and humanity insulin on CSII in type 2 diabetic patients胰岛素泵中应用赖脯胰岛素和重组人胰岛素治疗2型糖尿病疗效对照 4.Comparison of the Effect and Safety between Premixed Insulin Aspart 30 and Human Insulin Premix 70/30 in the Patients with Type 2 Dia...
Insulin lispro is contraindicated in patients who are sensitive to this analogue. Because hypokalaemia is a potential adverse effect of all insulins, caution is advised in patients who are fasting, in those who have autonomic neuropathy and in those receiving potassium-lowering agents. The effects...
14.The controll observation of insulin lispro 75/25 and actrapid monotard 70/30 on treatment of type 2 diabetes赖脯胰岛素75/25和人胰岛素70/30治疗2型糖尿病的对照观察 15.The therapeutic effects of insulin lispro and humanity insulin on CSII in type 2 diabetic patients胰岛素泵中应用赖脯胰岛素和...
6.The therapeutic effects of insulin lispro and humanity insulin on CSII in type 2 diabetic patients胰岛素泵中应用赖脯胰岛素和重组人胰岛素治疗2型糖尿病疗效对照 7.The Effect of Intensive Insulin Therapy on the Insulin Resistance in Postoperative Gastric Cancer Patients Underwent Different Nutritional Supp...
The glucose lowering effect of intravenous administration of another insulin lispro product, 100 units/mL, was tested in 21 patients with type 1 diabetes. For the study, the patients’ usual doses of insulin were held, and blood glucose concentrations were allowed to reach a stable range of 20...
DiMarchi is the inventor of Lilly's insulin analogue Lispro (marketed as Humalog), covered by patent US 5,514,646. Insulin molecules tend to form stable hexamers in solution, leading to a delay between injection or inhalation and therapeutic effect. Slight structural modifications in Lispro result...
insulin lispro or aspart immediately before a standard mixed meal.RESULTS—With respect to blood glucose excursions from time 0 to 6 h (Excglu(0–6 h)) and from time 0 to 4 h (Excglu(0–4 h)), the pharmacodynamic effect of insulin aspart and insulin lispro can be declared equivalent....
Patients received either 0.4 U/kg/day lispro mix (50% insulin lispro protamine and 50% insulin lispro) subcutaneously (SC) in three equal doses plus 2000 mg/day oral metformin; 0.4 U/kg/day insulin aspart (30% insulin aspart and 70% protamine insulin aspart) SC in two equal doses plus...
11. The method of claim 1, wherein the formulation is comprised of insulin lispro. 12. The method of claim 1, wherein the exhaled volume of air in step (a) is determined by instructing the patient to exhale to the maximal extent possible. 13. The method of claim 1, wherein the ...
The Lispro insulin analog is a recently developed compound whose faster kinetics as compared to soluble insulin ensure an effect that is closer to the physiologic postprandial profile. When injected just before a meal, the Lispro analog is more effective in blunting the postprandial blood glucose ...